Ovid Therapeutics Inc. (OVID) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 120.19M |
| Enterprise Value | 120.46M |
| P/E Ratio | -7.08 |
| PEG Ratio | 0.13 |
| Price/Sales Ratio | 45.37 |
| Price/Book Ratio | 0.91 |
| Enterprise/Revenue | 32.37 |
| Enterprise/EBITDA | -9.6 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | -3.39 |
| Operating Margin | -6.7 |
AD
Management Effectiveness
| Return On Assets | -0.11 |
| Return On Equity | -0.23 |
Income Statement
| Revenue | 7.25M |
| Revenue/Share | 0.1 |
| Gross Profit | 6.95M |
| EBITDA | -17.11M |
| Net Income | -17.41M |
| Diluted EPS | -0.24 |
Balance Sheet
| Total Cash | 155.52M |
| Total Cash/Share | 2.11 |
| Total Debt | 1.46M |
| Total Debt/Equity | 0.01 |
| Current Ratio | 10.17 |
| Book Value Per Share | 2.69 |
Price History
| 52-Week Change | 517.28 |
| 52-Week High | 3.11 |
| 52-Week Low | 0.36 |
| Moving Average 50 Days | 2.56 |
| Moving Average 200 Days | 1.97 |
Statistics
| Average Volume | 2.6M |
| Shares Outstanding | 131.88M |
| % Held by Institutions | 142.49 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
